Cogent Biosciences, Inc. (COGT) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of Cogent Biosciences, Inc. and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.87HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
SRRK
Scholar Rock Holding Corporation
$43.40HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — COGT vs SRRK
growth of $100 · dividends reinvested · last 8yCOGT -32.7% (-4.8%/yr)SRRK +180.0% (+13.7%/yr)SRRK compounded faster over this window
COGT SRRK
COGT vs SRRK: by the numbers
- •COGT is the larger company ($5.27B vs $5.20B market cap).
Metrics side by side
Valuation
| Metric | COGT | SRRK |
|---|---|---|
| P/B ratio | 11.28 | 20.49 |
Profitability
| Metric | COGT | SRRK |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -70.85% | -161.00% |
| ROIC | -50.09% | -90.04% |
Growth (annualized)
| Metric | COGT | SRRK |
|---|---|---|
| Total return CAGR (5Y) | 28.51% | 8.20% |
Frequently asked
- How have COGT and SRRK total returns compared?
- Over the past 5 years, COGT delivered 28.51% and SRRK delivered 8.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.